Clinical severe hepatic venoocclusive disease during induction treatment of acute monoblastic leukemia managed with defibrotide

American Journal of Hematology

Volumn 69, Issue 4, 2002, Pages 281-284

  Bairey, Osnat ^a,b   Kirgner, Ilia ^a   Yakobi, Moshe ^a   Hamdan, Ashraf ^a   Ben Ari, Ziv ^a   Shaklai, Mati ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

Acute monoblastic leukemia; Cytosine arabinoside; Defibrotide; Induction treatment; Venoocclusive disease

Indexed keywords

CYTARABINE; DEFIBROTIDE;

ACUTE MONOCYTIC LEUKEMIA; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; LIVER VEIN OBSTRUCTION; PRIORITY JOURNAL; REMISSION; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; CYTARABINE; DAUNORUBICIN; FEMALE; FIBRINOLYTIC AGENTS; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; LEUKEMIA, MONOCYTIC, ACUTE; LIVER; MIDDLE AGED; POLYDEOXYRIBONUCLEOTIDES;

EID: 0036202119     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10072     Document Type: Article

References (23)

1. Hepatic veno-occlusive disease
2. The syndrome of hepatic veno-occlusive disease after marrow transplantation
3. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients
4. Veno-occlusive disease of the liver after chemotherapy of acute leukemia
5. Venoocclusive disease of the liver: Development of a model for predicting fatal outcome after marrow transplantation
6. Chemotherapeutic agents and hepatotoxicity
7. Hepatic dysfunction and jaundice following high-dose cytosine arabinoside
8. Hyperbilirubinemia during induction therapy of acute granulocytic leukemia
9. Jaundice and hyperbilirubinemia following fludarabine, cytarabine, and idarubicin
10. Jaundice and hepatorenal syndrome associated with cytosine arabinoside
11. Incidence and outcome of hepatic veno-occlusive disease after blood or bone marrow transplantation: A prospective cohort study of the European Group for Blood and Marrow Transplantation
12. A comparison of clinical criteria for the diagnosis of veno-occlusive disease of the liver after bone marrow transplantation
13. Arabinosyl cytosine: A useful agent in the treatment of acute leukemia in adults
14. Fatal veno-occlusive disease of the liver following high dose chemotherapy, irradiation and bone marrow transplantation
15. Venoocclusive disease of the liver after chemotherapy with vincristine, actinomycin D, and cyclophosphamide for the treatment of rhabdomyosarcoma. A report of The Intergroup Rhabdomyosarcoma Study Group
16. Postremission therapy with two different dose regimens of cytarabine in adults with acute myelogenous leukemia
17. Veno-occlusive disease of the liver after marrow transplantation. Histological correlates of clinical signs and symptoms
18. Hepatic veno-occlusive disease in a patient with lupus anticoagulant after allogeneic bone marrow transplantation
19. Defibrotide: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disorders
20. An integrated view of the activities of defibrotide
21. Treatment of severe veno-occlusive disease with defibrotide: Compassionate use results in response without significant toxicity in a high-risk population
22. Defibrotide as salvage therapy for refractory venoocclusive disease of the liver complicating allogeneic bone marrow transplantation
23. Defibrotide for the treatment of hepatic veno-occlusive disease: Results of the European compassionate-use study